Healthcare

  Healthcare Automation Market   accounted for US$ 54.05 billion in 2020 and is estimated to be US$ 97.30 billion by 2030 and is anticipated to register a CAGR of 6.1%. Healthcare automation means implementation of advanced IT technologies to various processes, devices, and other applications in healthcare system. The transformation of healthcare system to automation tends to offer various benefits such as increased productivity, increased operational efficiency, reduced cost, and better management of processes as well as information. According to leading global watch dogs, ageing population is expected to emerge as major demographic change over the span of next decades. This means increased number of people requiring medical assistance, healthcare automationin turn is expected to solve this issue in a better way. The advent of healthcare automation has impacted or boosted following applications patient management, medical workflow, surgery management, logistics, diagnostic la...

  knee replacement market  accounted for 9.7 billion in 2020 and is estimated to be US$ 14.2 billion by 2029 and is anticipated to register a CAGR of 4.3%. The report " Global Knee Replacement Market, By Product ( Total Knee Replacement, Partial Knee Replacement, Kneecap Replacement, and Complex (or revision) Knee Replacement),  By End Users ( Hospitals, Orthopedic Centers, and Other ),  and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029” . Key Highlights: In March 2018, Smith and Nephew announced commercial release of bi-cruciate retaining Journey II XR total knee arthroplasty across the U.S. and Japan. The product launch was aimed at capturing large customer base with innovative product offering. In October 2018, Zimmer Biomet Holdings announced to collaborate with Apple to facilitate patient and surgeon connection during the knee and hip replacement procedures. Th...

  Medical Electrode Market   accounted for US$ 1.63 billion in 2020 and is estimated to be US$ 2.49 billion by 2030 and is anticipated to register a CAGR of 4.3%. Medical industry deploys several sorts of electrodes like electrocardiography (ECG) electrodes, fetal scalp electrodes, electroencephalography electrodes, transcutaneous electrical nerve stimulation TENS electrodes, pacemaker electrodes et al. across the world. An electrode may be a medical device capable of transferring ionic current energy into electrical current within the body which will be amplified to treat also as diagnose several ailments and life threatening conditions. With an increase within the global anticipation level and burgeoning population, number of chronic and severe disease statistics has witnessed an exponential rise in past decade itself. Average annual mortality thanks to other neurological diseases was 18.8/100,000, including Alzheimer's disease and other dementias 7.1/100,000 and paralysis a...

  Healthcare RFID Market   accounted for US$ 1.72 billion in 2020 and is estimated to be US$ 5.90 billion by 2030 and is anticipated to register a CAGR of 13.3%. RFID is a wireless technique that extracts a unique identity from microelectronic tags affixed to objects, allowing for automatic and unambiguous identification without the need for line of sight. Manufacturing, supply chain, agriculture, transportation, healthcare, and services are just a few of the industries where radio frequency identification (RFID) solutions have proved successful. Building a safer healthcare system could help to prevent medical blunders. RFID has recently been used in hospital administration. The RFID is useful for swiftly retrieving patient information and keeping track of where patients are in the hospital. The report " Global Healthcare RFID Market, By Type (Active RFID and Passive RFID), Frequency (Low Frequency, High Frequency & Near Field Communication, Ultra Frequency,...

The report  “ Global Connected Healthcare Market, By Function (Telemedicine, Home Monitoring, Assisted Living, and Clinical Monitoring), By Type (e-Prescription, mHealth Services, and mHealth Devices), By Application (Diagnosis & Treatment, Monitoring Applications, Education & Awareness, Wellness & Prevention, Healthcare Management, and Others), and Region - Global Forecast to 2030"    Connected Healthcare Market  accounted for US$ 39.3 billion in 2020 and is estimated to be US$ 962.70 billion by 2030 and is anticipated to register a CAGR of 38.1%. Global connected healthcare market driven by increasing usage of internet in developed and developing countries and growing government expenditure on the healthcare sector. Key Highlights: In January 2018, GE Healthcare has partnered with UE Lifesciences, a start-up, to come up with a handheld device that detects breast cancer. In November 2018, Medtronic, plc., along with Nutrino, announced that the compa...

Electronic Health Record   System Market accounted for US$ 25.5 billion in 2020 and is estimated to be US$ 38.9 billion by 2030 and is anticipated to register a CAGR of 4.30%. The systems that are used to maintain the digital health records of the patients, which supports the systemic storage of health progress, vital signs, medications, lab data and medical history are called as electronic health record systems. There is a minimum risk of losing it with less manual work and easy access of the information as the data is stored electronically. Health record systems allows easy sharing of the data with other healthcare professionals in order to take decisions related to patient’s health. It also allows to get connected with different sections of healthcare departments to collect the patient’s data. The report  "   Global Electronic Health Record System Market (EHR), By Product Type (Web/Cloud Based EHR Systems and Client Server Based EHR), By End User (Hospitals and Ambulat...

Ranitidine Market   accounted for US$ 441.24 million in 2020 and is estimated to be US$ 562.09 million by 2030 and is anticipated to register a CAGR of 2.5%. Ranitidine, sold under the name Zantac among others, may be a medication that's wont to decrease stomach acid production. It’s commonly utilized in treatment of peptic ulceration disease, esophageal reflux disease, and Zollinger–Ellison syndrome. It are often given orally, injection into a muscle, or injection into a vein. Common side effects include headaches and pain or burning if given by injection. Serious side effects may include liver problems, a slow pulse, pneumonia, and therefore the potential of masking stomach cancer. It is also linked to an increased risk of Clostridium difficile colitis. It's generally safe in pregnancy. Ranitidine is an H2 histamine receptor antagonist that works by blocking histamine, thus decreasing the quantity of acid released by cells of the stomach The report “ Global Ranitidine Market ...